Sterling Capital Management LLC Crinetics Pharmaceuticals, Inc. Transaction History
Sterling Capital Management LLC
- $7.74 Trillion
- Q3 2024
A detailed history of Sterling Capital Management LLC transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Sterling Capital Management LLC holds 80 shares of CRNX stock, worth $4,713. This represents 0.0% of its overall portfolio holdings.
Number of Shares
80Holding current value
$4,713% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CRNX
# of Institutions
246Shares Held
82MCall Options Held
268KPut Options Held
197K-
Vanguard Group Inc Valley Forge, PA6.29MShares$370 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.23MShares$367 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.11MShares$360 Million2.95% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.94MShares$291 Million0.03% of portfolio
-
Wellington Management Group LLP Boston, MA4.46MShares$263 Million0.04% of portfolio
About Crinetics Pharmaceuticals, Inc.
- Ticker CRNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,752,800
- Market Cap $3.17B
- Description
- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...